DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Maguire AM, Russell S, Wellman JA. et al.
Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials.
Ophthalmology 2019;
216: 1273-1285
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.